The Project ATA: Adipose Tissue & Adipokines
ATA
Adipose Tissue & Adipokines (ATA): From Laboratory to Clinical Practice - The Project ATA
1 other identifier
observational
378
1 country
1
Brief Summary
It is essential to delve deeper into the molecular and tissue aspects that allow us to recognize the roles of adipose tissue and its interaction with the musculoskeletal (i.e., adipomyokines) to facilitate the identification of biomarkers that can complement the assessment of body composition. Thus, investigators posed the following research question: what characteristics of adipose tissue can investigators consider to rethink assessment for the diagnosis and treatment of obesity? The 'Project ATA' is a cross-sectional study based on the Strengthening the Reporting of Observational Studies in Epidemiology-Nutritional Epidemiology (STROBE-nut) guidelines, an Extension of the STROBE Statement. The FINER strategy (Feasible, Interesting, Novel, Ethical, and Relevant) and previously published guidelines for organizing a multicenter study will be followed. The 'Project ATA' will test the associations of several morphological metrics and adipomyokines in order to both profile populations with excess body fat and to establish practical geographical-based recommendations for practitioners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedStudy Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedSeptember 7, 2023
September 1, 2023
5 months
February 6, 2023
September 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Anthropometric Assessment
All measurements will be performed according to the International Standards for Anthropometric Evaluation published by the International Society for the Advancement of Kineanthropometry (ISAK) to obtain basic measurements expressed in absolute data. Means will be calculated and analyzed from two measurements of anthropometric data.
July 2023 to August 2024
Anthropometry-Based Analysis of Body Composition
The whole-body fat percentage (RFM), the sum of skinfolds, the waist girth (minimal and umbilicus), the body mass to waist girth, waist girth to stature ratios. Finally, musculoskeletal index, the skinfold-corrected muscle girths for the arm, chest, waist, thigh, and calf will be calculated according to the expression: girth - (π x skinfold).
July 2023 to August 2024
Bioelectrical Impedance Analysis
To evaluate adult subjects with excess adiposity by foot-to-foot bioelectrical impedance analysis (BIA). Estimated values of percent fat mass (FM), percent muscle mass (MA), metabolic age (ma), basal metabolic rate (BMR), and visceral fat (VFL). In addition, bioelectrical impedance vector analysis (BIVA) will be performed and raw variables related to phase angle and body composition will be reported.
July 2023 to August 2024
Adipokines and blood screening
Will be collected peripheral blood samples, where it will be taken into account serum amyloid A, resistin, leptin, adiponectin, and visfatin concentrations will be quantified by direct chemiluminescence using acridinium ester technology.
July 2023 to August 2024
Study Arms (1)
Multi-center study
The study population will be inhabitants of both sexes with different levels of physical activity who reside in the metropolitan area of cities in Colombia, Mexico, Costa Rica, and Spain. The population sample will be obtained through an internal call to students and administrative personnel of universities and Smart Fit sites with an inter-institutional collaboration agreement with Dynamical Business \& Science Society (DBSS International). The first study will be carried out in Colombia.
Eligibility Criteria
The study population will be inhabitants of both sexes with different levels of physical activity who reside in the metropolitan area of cities in Colombia, Mexico, Costa Rica, and Spain. Investigators will primarily consider university students, administrative personnel, and other potentially eligible adults of both sexes who respond to the study announcement, fulfill inclusion criteria and sign the informed consent form. To understand the prevalence or proportion of a given phenotype among adults in a city a formula based on previously reported proportions will be used to calculate the sample size.
You may qualify if:
- People over 18 years of age (under 60 years of age).
- People born and residing in major cities or neighboring municipalities of the metropolitan area of selected cities. The first stage will take place in Medellín (Colombia) and then continue in other cities in Colombia, Costa Rica, Mexico, and Spain according to logistics procedures.
- Those who sign the informed consent to undergo the measurements.
You may not qualify if:
- Those physically active people who exercise vigorously and systematically or at a competitive level.
- Those diagnosed with a musculoskeletal disease and/or special condition that limits mobility during the taking of measurements (musculoskeletal injury).
- People over 60 years of age.
- Pregnant women.
- People with implants or synthetic prostheses.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Dynamical Business and Science Society - DBSS International SASlead
- CES Universitycollaborator
- Universidad de Córdobacollaborator
Study Sites (1)
DBSS
Bogotá, 110311, Colombia
Related Publications (3)
Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. 2016 Jun;22(7 Suppl):s176-85.
PMID: 27356115BACKGROUNDBonilla DA, De Leon LG, Alexander-Cortez P, Odriozola-Martinez A, Herrera-Amante CA, Vargas-Molina S, Petro JL. Simple anthropometry-based calculations to monitor body composition in athletes: Scoping review and reference values. Nutr Health. 2022 Mar;28(1):95-109. doi: 10.1177/02601060211002941. Epub 2021 Apr 1.
PMID: 33792415BACKGROUNDBremner JD, Moazzami K, Wittbrodt MT, Nye JA, Lima BB, Gillespie CF, Rapaport MH, Pearce BD, Shah AJ, Vaccarino V. Diet, Stress and Mental Health. Nutrients. 2020 Aug 13;12(8):2428. doi: 10.3390/nu12082428.
PMID: 32823562BACKGROUND
Biospecimen
Peripheral blood samples will be collected from the forearm veins of the participants to quantify the concentration of adipokines and lipid profile.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Diego A Bonilla, MSc
Research Division, Dynamical Business & Science Society - DBSS International SAS, Bogotá, Colombia
- PRINCIPAL INVESTIGATOR
Luis M Gómez-Miranda, PhD
Sports School, Autonomous University of Baja California, Tijuana 22390, México
- PRINCIPAL INVESTIGATOR
Daniel Rojas-Valverde, PhD
Núcleo de Estudios para el Alto Rendimiento y la Salud (CIDISAD-NARS), Heredia, Costa Rica
- PRINCIPAL INVESTIGATOR
Salvador Vargas-Molina, MSc
Faculty of Sport Sciences, EADE-University of Wales Trinity Saint David, 29018 Málaga, Spain
- PRINCIPAL INVESTIGATOR
Katherine Franco-Hoyos, MSc
Nutral, Universidad CES, Medellín, Colombia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2023
First Posted
March 7, 2023
Study Start
January 1, 2024
Primary Completion
June 1, 2024
Study Completion
December 1, 2024
Last Updated
September 7, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
The data collected in this study will be used for research purposes, according to the bioethical standards established by the Institutional Review Board (IRB) and the procedures will be developed in accordance with the latest version of the Declaration of Helsinki. Investigators will not share the identity of those who participate in the research. The information investigators collect in this research project will be kept confidential, will be kept off-limits, and no one except the researchers will have access to it. Any information about the participant will have an identifying number (rather than the name) at the time of analysis. Only the researchers will know what the number is and the information will be kept confidential. It will not be shared or given to anyone except participants, a Data and Safety Monitoring Board (DSMB), or others participants authorize (e.g., physician, nutritionist).